{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:24:20Z","timestamp":1778876660570,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejso.2015.01.021","type":"journal-article","created":{"date-parts":[[2015,2,16]],"date-time":"2015-02-16T20:13:11Z","timestamp":1424117591000},"page":"641-646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"F.","family":"Aloraifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alshehhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Meany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"O'Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2015.01.021_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","article-title":"Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family","volume":"8","author":"Evans","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2015.01.021_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","article-title":"Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition","volume":"351","author":"Kriege","year":"2004","journal-title":"Engl J Med"},{"issue":"2","key":"10.1016\/j.ejso.2015.01.021_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"Engl J Med"},{"issue":"1","key":"10.1016\/j.ejso.2015.01.021_bib4","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","article-title":"Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource","volume":"8","author":"Mann","year":"2006","journal-title":"Breast Cancer Res"},{"issue":"10","key":"10.1016\/j.ejso.2015.01.021_bib5","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.24200","article-title":"BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer","volume":"115","author":"Hall","year":"2009","journal-title":"Cancer"},{"issue":"4985","key":"10.1016\/j.ejso.2015.01.021_bib6","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ejso.2015.01.021_bib7","first-page":"667","article-title":"A\u00a0serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"114","author":"Hemminki","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejso.2015.01.021_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.ejso.2015.01.021_bib9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2015.01.021_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","article-title":"Localization of the gene for Cowden disease to chromosome 10q22-23","volume":"13","author":"Nelen","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejso.2015.01.021_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1086\/302746","article-title":"ATM-heterozygous germline mutations contribute to breast cancer-susceptibility","volume":"66","author":"Broeks","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"17","key":"10.1016\/j.ejso.2015.01.021_bib12","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1073\/pnas.97.17.9603","article-title":"Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus","volume":"97","author":"Kainu","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.ejso.2015.01.021_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000123846","article-title":"The molecular pathology of hereditary breast cancer","volume":"75","author":"Palacios","year":"2008","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.ejso.2015.01.021_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10911-011-9204-6","article-title":"Phenotype-genotype correlation in familial breast cancer","volume":"16","author":"Vargas","year":"2011","journal-title":"J\u00a0Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.ejso.2015.01.021_bib15","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2015.01.021_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.01.021_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10549-008-0087-1","article-title":"Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumours","volume":"117","author":"Bane","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejso.2015.01.021_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1158\/1078-0432.CCR-05-2230","article-title":"Characterization of familial non-BRCA1\/2 breast tumours by loss of heterozygosity and immunophenotyping","volume":"12","author":"Oldenburg","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2015.01.021_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/gcc.20816","article-title":"Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families","volume":"49","author":"Balleine","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ejso.2015.01.021_bib20","first-page":"3606","article-title":"Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations differences from","volume":"9","author":"Palacios","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2015.01.021_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(05)70318-1","article-title":"Familial non-BRCA1\/BRCA2-associated breast cancer","volume":"6","author":"Eccles","year":"2005","journal-title":"Lancet Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejso.2015.01.021_bib22","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/modpathol.2010.37","article-title":"Pathology of hereditary breast cancer","author":"Da Silva","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.ejso.2015.01.021_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/00313020802035899","article-title":"Histopathological features of \u201cBRCAX\u201d familial breast cancers in the kConFab resource","volume":"40","author":"Loughrey","year":"2008","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.ejso.2015.01.021_bib24","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/bcr953","article-title":"Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families","volume":"7","author":"Eerola","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2015.01.021_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2015.01.021_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.ejso.2015.01.021_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/fon.13.278","article-title":"Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?","volume":"10","author":"Phillips","year":"2014","journal-title":"Future Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2015.01.021_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2015.01.021_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/312513a0","article-title":"The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen","volume":"312","author":"Schechter","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2015.01.021_bib30","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9880","key":"10.1016\/j.ejso.2015.01.021_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"Cuzick","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejso.2015.01.021_bib32","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.01.021_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1749-6632.2001.tb02726.x","article-title":"Hormonal prevention of hereditary breast cancer","volume":"952","author":"Narod","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"9354","key":"10.1016\/j.ejso.2015.01.021_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2015.01.021_bib35","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"NEJM"},{"issue":"7333","key":"10.1016\/j.ejso.2015.01.021_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature09796","article-title":"A\u00a0decade's perspective on DNA sequencing technology","volume":"470","author":"Mardis","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2015.01.021_bib37","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","article-title":"Update on the Manchester Scoring System for BRCA1 and BRCA2 testing","volume":"42","author":"Evans","year":"2005","journal-title":"J\u00a0Med Genet"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T01:29:39Z","timestamp":1537838979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0748798315000542"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.01.021","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}